A5014314894- Viral Infections and Immunology Research
- Viral gastroenteritis research and epidemiology
- CAR-T cell therapy research
- Financial Literacy, Pension, Retirement Analysis
- Housing, Finance, and Neoliberalism
- Microfinance and Financial Inclusion
- Housing Market and Economics
- Cytomegalovirus and herpesvirus research
- Neutropenia and Cancer Infections
- Gender, Labor, and Family Dynamics
- Virus-based gene therapy research
- Respiratory viral infections research
- Herpesvirus Infections and Treatments
- Hematopoietic Stem Cell Transplantation
- Rural development and sustainability
- Acute Myeloid Leukemia Research
- Regional Economic and Spatial Analysis
- RNA and protein synthesis mechanisms
- Intergenerational Family Dynamics and Caregiving
- Advancements in Semiconductor Devices and Circuit Design
- Monoclonal and Polyclonal Antibodies Research
- Energy, Environment, Economic Growth
- China's Socioeconomic Reforms and Governance
- Whipple's Disease and Interleukins
- Animal Disease Management and Epidemiology
Beijing Wantai Biological Pharmacy (China)
2024-2025
Beijing Tongren Hospital
2021-2024
Capital University of Economics and Business
2020-2024
Xiamen University
2018-2023
Beijing Fengtai Hospital
2022
iQIYI (China)
2020
East China University of Science and Technology
2020
Southwestern University of Finance and Economics
2003-2016
China Pharmaceutical University
2015
Southwest University
2003-2006
This study focuses on the impact of digital finance households. While has brought financial inclusion, it also increased risk households falling into a debt trap. We provide evidence that supports this notion and explain channel through which increases likelihood distress. Our results show widespread use credit market participation. The broadened access to markets household consumption by changing marginal propensity consume. However, easier
Abstract Despite worldwide promising clinical outcome of CD19 CAR-T therapy, relapse after this therapy is associated with poor prognosis and has become an urgent problem to be solved. We conducted a CD22 CAR T-cell in 34 relapsed or refractory (r/r) B-ALL pediatric adult patients who failed from previous therapy. Complete remission (CR) CR incomplete count recovery (CRi) was achieved 24 30 (80%) that could evaluated on day infusion, which accounted for 70.5% all enrolled patients. Most only...
Abstract The prognosis of relapsed acute lymphoblastic leukemia (ALL) after allogeneic transplantation is dismal when treated with conventional approaches. While single‐target CD19 or CD22 chimeric antigen receptor (CAR) T‐cell therapy has achieved high complete remission (CR) rates in refractory/relapsed B‐ALL, it could not maintain a durable most patients. To prolong relapse‐free survival, we sequentially combined and CAR‐T cells to treat post‐transplant B‐ALL patients both CD19/CD22...
Human enteroviruses (EVs) are the most common causative agents infecting human, causing many harmful diseases, such as hand, foot, and mouth disease (HFMD), herpangina (HA), myocarditis, encephalitis, aseptic meningitis. EV-related diseases pose a serious worldwide threat to public health. To gain comprehensive insight into seroepidemiology of major prevalent EVs in humans, we firstly performed serological survey for neutralizing antibodies (nAbs) against Enterovirus A71 (EV-A71), Coxsackie...
Abstract Background For CD19-positive relapsed/refractory B-cell acute lymphoblastic leukemia (r/r B-ALL) after treatment with murine CD19 (mCD19) CAR-T, the reinfusion of mCD19 CAR-T cells may be ineffective due to anti-mouse single-chain variable fragment (scFv) antibody caused by CAR. To overcome this immunogenicity, we applied humanized (hCD19) treat r/r B-ALL patients prior therapy. Methods Nineteen pediatric and adult were included, 16 relapsed 3 primarily resistant CAR-T. All...
Isolation of the first neutralizing antibody CVA10 and mechanism underlying its potency against all three existing capsid forms.